Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

FDA classifies Abbott’s blood pumping system recall as most serious

The U.S. Food and Drug Administration classified the recall of Abbott Laboratories’ CentriMag blood pumping system, following the death of a patient, as Class 1 or the most serious type of recall.

Read More »

Stryker boosts bone implants with $4 billion Wright Medical buyout

Medical device maker Stryker Corp. will buy smaller rival Wright Medical Group for about $4 billion in cash, expanding into the fast-growing business of implants for shoulders and wrists.

Read More »

EVERSANA to acquire Cornerstone Research Group

EVERSANA, a leading independent provider of commercial services to the life science industry, announced an agreement to acquire Canada-based Cornerstone Research Group Inc.

Read More »

Johnson & Johnson agrees to pay about $117 million to settle vaginal mesh litigation

U.S. state attorneys general said Johnson & Johnson and a company unit agreed to pay nearly $117 million to settle litigation over deceptive marketing of transvaginal surgical mesh devices.

Read More »

QIAGEN and Illumina Partner to Deliver Sequencing-Based IVD Tests

Illumina Inc. and Qiagen N.V. announced a 15-year partnership intended to broaden the availability and use of NGS-based in-vitro diagnostic (IVD) kits, including companion diagnostics, for patient management.

Read More »

Accelmed seeks to raise $100 million for fourth health tech fund

Accelmed, a U.S.-Israel group of funds investing in medical device and digital health companies, is establishing a new fund with the aim of raising and managing $100 million.

Read More »

Favorable court ruling for Vectura and Sandoz vs. GSK

A British court ruled in favor of Vectura Group and the company’s partner Sandoz over the packaging of a generic version of an inhaler made by bigger rival GlaxoSmithKline.

Read More »

FDA green lights AstraZeneca’s asthma drug Fasenra for self-administration

The U.S. Food and Drug Administration approved self-administration of AstraZeneca’s asthma treatment Fasenra which uses a pre-filled, single-use auto-injector pen.

Read More »

Abbott Announces European Approval of Two Life-saving Heart Devices for Babies and Children

Abbott announced approvals in Europe for two life-saving pediatric devices, the Masters HP 15mm rotatable mechanical heart valve and the Amplatzer Piccolo Occluder.

Read More »

Orchestra BioMed Announces FDA Breakthrough Device Designation for Virtue Sirolimus-Eluting Balloon

Orchestra BioMed Inc., in partnership with Terumo Corporation, announced Breakthrough Device Designation was granted by the U.S. Food and Drug Administration for the biomedical innovation company’s Virtue Sirolimus-Eluting Balloon in the treatment of below-the-knee peripheral artery disease.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2019 Focus: Top 50 Company Profiles & Financials, Outcomes Creativity Index, and more!


Ad Right Bottom